Loading clinical trials...
Loading clinical trials...
Inr Tracking With Face-To-Face And Phone App: A Randomized Controlled Trial
This study aims to compare the INR values of the patients followed by face-to-face and telephone applications.
Warfarin has a narrow therapeutic window. Maintaining the patient's international normalized ratio (INR) within the predefined therapeutic range is one of the main challenges of warfarin treatment. This study was designed as a randomized controlled experiment. Twelve patients living in a distant place were assigned to the experimental group, and 12 patients living nearby and followed in the outpatient clinic were assigned to the control group. A Patient Information Form and the Adherence to Refills and Medications Scale were used to collect data.
Age
18 - 90 years
Sex
ALL
Healthy Volunteers
No
Ahi Evren Göğüs Kalp ve Damar Cerrahisi Eğitim ve Araştırma Hastanesi
Trabzon, Turkey (Türkiye)
Start Date
June 1, 2021
Primary Completion Date
November 30, 2022
Completion Date
November 30, 2022
Last Updated
February 8, 2023
24
ACTUAL participants
mobile applications with the name "Set My INR"
OTHER
Lead Sponsor
Muhammed Onur Hanedan
NCT06860425
NCT06653049
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT05157919